What's breaking now, across thousands of outlets.
Key PointsTempus AI stock surged this week after Merck and Moderna published encouraging trial results for a cancer treatment.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Key PointsDeborah Weitzman sold 7,354 shares for approximately $1.7 million on August 18.
Two numbers suggest this is the moment for holders of the stock, and for opportunistic traders, to think seriously about downside protection, says Scott Nations.
Mary C. Scherer reduced her direct equity but retains 2,811 shares after the stock delivered a 58% return over the past year.
As RBI largely maintains hands-off approach to intervention
